Krystal Biotech, Inc. 4

Dino A. Rossi gifted 3,691 shares and sold 24,000 shares of Krystal Biotech, Inc. Common Stock on August 14, 2026, leaving him with 50,000 shares owned directly.

On August 14, 2026, Dino A. Rossi of Krystal Biotech, Inc. reported a bona fide gift of 3,691 shares of Common Stock to a charitable donor-advised fund, reducing his direct holdings from 75,000 to 75,000 − 3,691 = 71,309 shares before further activity. On the same date, he executed a series of open-market sales of Common Stock in multiple tranches: 341 shares at a weighted average price of $325.5985, 2,287 shares at $326.6028, 5,226 shares at $327.3939, 1,687 shares at $328.5152, 7,428 shares at $329.6015, 4,896 shares at $330.3558, 3,095 shares at $331.4333, and 40 shares at $333.23. In aggregate, he sold 24,, per the filing, with each tranche executed over multiple trades within the specified price ranges, for an estimated total sale value of approximately $7.99 million. After these transactions, Rossi reported direct ownership of 50,000 shares of Krystal Biotech Common Stock. Using the prevailing transaction prices (~$330 per share) as a proxy, his post-transaction holdings are worth roughly $16.5 million.

Filing Facts

CIK

1711279

Ticker

KRYS

Form

4

Source Type

fda

Accession

0001209059-26-000006

Alert Tier

7